A breakdown in law enforcement has led to an increase of the poaching of Zimbabwe’s rhinoceros. Conservationists are highly concerned about the drastic increase in the slaying of the beautiful animal for its valuable horns. (more…)

India has always been renown as a destination for the best in medicine at a competitive price when compared to other places. Not so anymore, as more and more foreign firms like Itero, enter into partnership with Indian companies with an eye on contracts and future profits. The Indian doctors are one of the best the world over and their reputation is well deserved. It is not just the doctors but the medical research firms that are equally excellent, it is no wonder that many foreign firms, especially in the field of biotechnology are making a beeline to this country.

Itero is currently located in California and has just entered into a partnership with the Indian firm Biological E. Their partnership is more or less based on providing the equitable financial assistance to joint research projects and to commercialize it in India as well as the world over. Naturally under this agreement, Itero retains the right to market such products in the United States, Japan and Europe while Biological E retains the right to do the same in the other countries, read Australiasia.В  Itero will provide the required funding for the development cycle where as Biological E will do so for the manufacturing part.

According to Dr. Bryan Lawli, the chief executive officer of Itero, they had settled upon Biological E after a very exhaustive search. It was their expertise in biologics manufacturing and commercialization that settled the deal for them. Taking into account the operational experience that Biological E has both in India as well as the United States, Bryan Lawlis feels that the company as a whole would stand to benefit from such a partnership and that one can hope for great things to happen, here and overseas as a result of this.

В 

The next time you need a tablet to relieve your hypertension problems, you may want to try out the new Ramipril tablets instead of the Altace tablets. Lupin limited, a well known pharmaceuticals based in Bombay has managed to get the final go ahead to introduce their version of the Altace tablets to the American markets. Lupin decided to come out with their own generic version of the age old Altace and in spite of legal hurdles initiated by King pharmaceuticals they have managed to prevail.

The new version of the Altace tablets offers the American consumers a much better alternative when it comes alleviating their hypertension problems. For one, it is alleged to be quicker than the old version and is priced competitively. The US Food and Drug administration has granted its approval of the Ramipril capsules in the 1.25 mg, 2.5mg, 5mg and the 10 mg varieties.

Lupin has become the very first company to successfully challenge the hold that Altace tablets have had on the American consumer market and win it. The new and the generic form of the old meds forbears interesting times ahead with more generic forms of old formulas due to hit the markets in the near future. The patients as well as the American markets are set to benefit as a result of new entrants like Ramipril on account of their effectiveness as well as the range of prices they offer. With effective medicine being made available, one can hope that the burden on the American healthcare would decrease with time.

В